These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cell-matrix patterns in the cutaneous lesion of chromomycosis. Esterre P; Peyrol S; Guerret S; Sainte-Marie D; Pradinaud R; Grimaud JA Pathol Res Pract; 1992 Oct; 188(7):894-900. PubMed ID: 1448381 [TBL] [Abstract][Full Text] [Related]
3. [Chromomycosis: report of a case with unusual topography]. Muñoz Estrada VF; Valenzuela Paz GA; Rochín Tolosa M Rev Iberoam Micol; 2011; 28(1):50-2. PubMed ID: 21167297 [TBL] [Abstract][Full Text] [Related]
4. Chromomycosis in Tanzania. van Raalte JA; Venkataramaiah NR Trop Geogr Med; 1982 Mar; 34(1):39-42. PubMed ID: 7080185 [TBL] [Abstract][Full Text] [Related]
15. Chromomycosis: a twenty-year analysis of histologically confirmed cases in Jamaica. Bansal AS; Prabhakar P Trop Geogr Med; 1989 Jul; 41(3):222-6. PubMed ID: 2595799 [TBL] [Abstract][Full Text] [Related]
16. Six years' experience in treatment of chromomycosis with 5-fluorocytosine, Lopes CF; Alvarenga RJ; Cisalpino EO; Resende MA; Oliveira LG Int J Dermatol; 1978 Jun; 17(5):414-8. PubMed ID: 659043 [TBL] [Abstract][Full Text] [Related]
17. Persistent viability of the Medlar body. Rosen T; Overholt M Int J Dermatol; 1996 Feb; 35(2):96-8. PubMed ID: 8850035 [TBL] [Abstract][Full Text] [Related]
18. [Fonsecaea pedrosoi-caused chromoblastomycosis in the state of Maranhão. I. The clinical, epidemiological and evolutionary aspects]. Mello e Silva AC; Serra Neto A; Galvão CE; Marques SG; Saldanha AC; Pedroso e Silva CM; Fischman O; da Silva RR; Costa Mdo R; Costa JM Rev Soc Bras Med Trop; 1992; 25(1):37-44. PubMed ID: 1308064 [TBL] [Abstract][Full Text] [Related]